上海建橋教育暗盤僅升7.1%,今日上市或補漲。
格隆匯1月16日丨2020年第一隻教育股上海建橋教育(1525.HK)今日上市。昨日公司公告其國際配售超購2.5倍,而公開發只則錄得4.5倍的超購。據瞭解,國際配售部份引入了不少大型國際基金成為長線投資者,連同三大基石投資者國貿教育、几几拓力投資及夢百合(603313.SH),相信大部分貨源已進入大型基金手中,對後市股價有良好支持作用。 公司以下限6.05港元定價上市,投行指2020年預測市盈率僅8.8倍,較同業平均20倍呈大幅折讓,反映公司為投資者預留水位,帶來一份新春禮物。近日,港股教育股表現強勢,不少教育股如科培教育(1890)已創下52周新高,上海建橋教育暗盤大漲7.1%,報6.48港元,今日開市或會進一步補漲。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.